Cybin
HELP
10.51
-0.25
-2.32%
Cybin
US · HELP
#3447 by market cap
10.51
-0.25
-2.32%
Live - 5344 symbols - heartbeat 124s ago
· 2026-10-08 09:12
Pre-market
10.51
0.00%
After-hours
10.83
+3.04%
Overnight
10.51
0.00%
- Market cap
- 767.86M
- P/E (TTM)i
- -2.47
- P/Bi
- 3.31
- EPSi
- -4.25
- Div yieldi
- 0.00%
- 52W posi
- 59%
Reader sentiment
Are you bullish or bearish on HELP?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Company notice
Transaction Media Networks: TMN will begin supporting JR East's "teppay" from October 2026—TMN, which boasts a nationwide payment infrastructure of 1.2 million terminals, will help accelerate the swift deployment of this new payment brand in society.JPX · 2026/10/6
-
Focused Funds Can Help You Navigate a Top-Heavy Market -- Barrons.comBarron's · 2026/10/1
-
Company notice
EDION: We've launched the "Healing-Time Renovation" to help you unwind at home.JPX · 2026/9/30
-
Rating change
Juheshun (605166): First-Half Results Under Pressure; Optimized Production Capacity Mix and a Private Placement Help the Company Navigate the Cyclical Downturn.China Post Securities · 2026/9/1
-
Rating change
ReBio Pharma (06938.HK) posted first-half 2026 results that exceeded our expectations; inclusion in the Stock Connect program could help boost liquidity.CICC · 2026/9/2
-
Micron Technology CEO Says AI Is Becoming Super Intelligence, And Memory Enhances This Intelligence and the Competitiveness of Our Customers' Platforms; Increasing Investments in Technology, Products And Manufacturing to Help Drive SI Forward With...Benzinga · 2026/10/1
-
Company notice
Commerce One Holdings: Future Shop has launched a new CRM option, "future Engagement Cast powered by OmniSegment," which leverages AI to help drive sales growth.JPX · 2026/10/1
-
Rating change
Tongwei Co., Ltd. (600438) – 2026 Interim Report Commentary: Short-term profits under pressure; efforts to curb excessive competition could help drive up prices across the industry chain.Huachuang Securities · 2026/9/1
-
Rating change
CCORF Maintains Cybin(HELP.US) With Buy Rating, Maintains Target Price $42Market Newswire · 2026/9/23
-
Rating change
Rentokil Initial: Non-Core U.S. Disposal and Strategic Self-Help Support Buy Rating and Unchanged 484 GBp Price TargetTipRanks · 2026/9/22
-
Company notice
Members: We have launched a service to build and help embed the marketing decision‑making AI agent "AI‑CMO," providing end‑to‑end support—from enterprise‑level implementation to on‑the‑ground adoption and rapid PDCA cycles—so organizations can move beyond merely "introducing AI."JPX · 2026/9/30
-
Rating change
Shouhua Gas (300483): Rising gas prices boost short-term earnings, while increased volume and lower costs help build long-term growth potential.China Securities Co., Ltd. · 2026/9/2
-
Rating change
H.C. Wainwright Maintains Cybin(HELP.US) With Buy Rating, Maintains Target Price $70Market Newswire · 2026/9/22
-
Rating change
Tongwei Co., Ltd. (600438): Rising share of module exports; curbing excessive competition may help restore supply chain pricing.China Post Securities · 2026/9/11
-
Rating change
H.C. Wainwright Remains a Buy on Helus Pharma (HELP)TipRanks · 2026/9/22
-
Your Family Member Is Calling for Help. But Is It Really Them?PR Newswire · 2026/10/6
-
Company notice
Daiwa Securities Group: Yamato Connect Securities has launched a new service, "Connect's Accumulation‑Support Insurance," to help customers build wealth over the long term.JPX · 2026/10/5
-
CHAIRMAN AND CEO DAVID ELLISON ANNOUNCES YNON KREIZ CO-CEO OF THE ANTICIPATED COMBINED PARAMOUNT AND WARNER BROS. DISCOVERY AT CLOSING TO HELP BUILD THE NEXT-GENERATION GLOBAL MEDIA COMPANYPR Newswire · 2026/10/1
-
Jefferies Maintains Cybin(HELP.US) With Buy Rating, Maintains Target Price $22Market Newswire · 2026/10/5
-
Rating change
Wells Fargo Maintains Cybin(HELP.US) With Buy Rating, Maintains Target Price $16Market Newswire · 2026/9/1
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 09:12:08 · For reference only, not investment advice and not tailored to your situation.